Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
---|---|---|---|---|---|---|---|
Report Filing | 2025-04-15 | 2025-02-25 | 2024-02-27 | 2023-03-02 | 2022-02-24 | 2020-12-31 | 2019-12-31 |
Revenue | 228.2 | 226.7 | 201.5 | 157.6 | 125.8 | 98.68 | 61.33 |
Cost of Revenue | 58.96 | 59.42 | 60.95 | 52.83 | 49.59 | 34.85 | 20.25 |
Gross Profit | 169.3 | 167.3 | 140.6 | 104.8 | 76.18 | 63.83 | 41.08 |
Operating Expenses | 158.1 | 157.2 | 155.2 | 154.7 | 142.1 | 57.31 | 42.89 |
Research & Development | 55.76 | 53.62 | 60.12 | 57.2 | 45.19 | 19.04 | 12.69 |
Selling, General and Administrative | 100.7 | 102.3 | 93.13 | 96.15 | 95.41 | 37.8 | 30.87 |
Other Operating Expenses | 1.65 | 1.27 | 1.92 | 1.36 | 1.51 | 0.462 | -0.665 |
Operating Income | 11.16 | 10.1 | -14.6 | -49.92 | -65.93 | 6.52 | -1.81 |
Net Non-Operating Interest | 7.62 | 13.8 | 22.21 | -7.63 | 6.72 | -0.72 | -2.17 |
Interest Income | 8.68 | 14.17 | 23.76 | 23.77 | 7.41 | 0.556 | 0.334 |
Interest Expense | 1.05 | 0.371 | 1.54 | 31.4 | 0.696 | 1.28 | 2.51 |
Equity & Other Income/(Expense) | -2.72 | -14.24 | -18.2 | 1.11 | -10.78 | -2.34 | 0.288 |
Income Before Tax | 16.07 | 9.66 | -10.59 | -56.44 | -69.99 | 3.46 | -3.69 |
Income Tax Expense | 0.759 | -2.33 | 3.11 | -4.03 | -9.47 | 4.29 | 0.883 |
Income Attributable to Non-Controlling Interest | 0.008 | -0.003 | -0.007 | 0 | 0 | 0 | 0 |
Net Income | 15.3 | 12 | -13.69 | -52.42 | -60.51 | -0.825 | -4.58 |
Depreciation and Amortization | 3.97 | 4.36 | 5.02 | 4.62 | 4.07 | 2.4 | 2.53 |
EBITDA | 15.14 | 14.47 | -9.58 | -45.3 | -61.86 | 8.92 | 0.717 |
Earnings Per Share (EPS) | 0.083 | 0.065 | -0.073 | -0.27 | -0.32 | -0.004 | -0.024 |
Diluted Earnings Per Share | 0.08 | 0.062 | -0.073 | -0.27 | -0.32 | -0.004 | -0.024 |
Weighted Average Shares Outstanding | 182.9 | 185 | 186.4 | 190.7 | 191 | 190.1 | 190.1 |
Diluted Weighted Average Shares Outstanding | 188.5 | 192.3 | 186.4 | 190.7 | 191 | 190.1 | 190.1 |